Immunosuppressive properties of heterologous antilymphocytic sera prepared against thymocyte soluble fraction. 1.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D003601:Cytotoxicity Tests, Immunologic; D006084:Graft Rejection / Q000187:drug effects; D006386:Hemagglutination Tests; D006462:Hemolytic Plaque Technique; D007109:Immunity / Q000187:drug effects*; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D011817:Rabbits; D012756:Sheep / Q000276:immunology; D016038:Skin Transplantation; D013950:Thymus Gland / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum